US Broker Ratings

Edwards Lifesciences (EW) Stock Analysis: Navigating a 15.96% Upside in the Medical Devices Sector

Edwards Lifesciences Corporation (NYSE: EW), a prominent player in the healthcare sector specializing in medical devices, has garnered significant attention from investors, not least due to its potential upside of..

Gilead Sciences, Inc. (GILD) Stock Analysis: What Investors Need to Know About Its Strong ROE and Dividend Yield

Gilead Sciences, Inc. (NASDAQ: GILD) stands out in the healthcare sector as a formidable force in drug manufacturing. With a market capitalization of $168.66 billion, this biopharmaceutical giant has solidified..

Novo Nordisk A/S (NVO) Stock Analysis: Impressive ROE and Strategic Collaborations in Focus

Novo Nordisk A/S (NYSE: NVO), a titan in the healthcare sector, continues to capture the attention of investors with its commanding market presence and impressive financial metrics. As a leading..

The Cigna Group (CI) Investor Outlook: Analyzing Its 17% Potential Upside and Strong Buy Ratings

For investors navigating the complex waters of the healthcare sector, The Cigna Group (NYSE: CI) presents a compelling opportunity. With a market capitalization of $74.58 billion, this industry stalwart is..

CVS Health Corporation (CVS): Investor Outlook Highlights 14.40% Potential Upside

CVS Health Corporation (NYSE: CVS), a titan in the healthcare sector, stands as a compelling investment opportunity with a market capitalization of $105.38 billion. As a key player in the..

Boston Scientific Corporation (BSX) Stock Analysis: A 34% Potential Upside Amidst Strong Growth

Boston Scientific Corporation (NYSE: BSX), a leading player in the healthcare sector, is making waves in the medical devices industry with a market capitalization of $137.19 billion. As healthcare continues..

Haleon plc (HLN) Stock Analysis: A Promising 13.03% Potential Upside in the Healthcare Sector

For investors seeking exposure in the healthcare sector, Haleon plc (HLN) presents an intriguing opportunity with a potential upside of 13.03%, according to analyst targets. Haleon operates in the specialty..

Sanofi (SNY) Investor Outlook: A Healthcare Giant with a 23% Upside Potential

Sanofi (SNY), a leading player in the global healthcare sector, offers a compelling investment opportunity for individual investors with a keen focus on the drug manufacturing industry. Headquartered in Paris,..

Eli Lilly & Co. (LLY) Stock Analysis: A $954 Billion Pharma Giant with Robust Revenue Growth and Promising Upside

Eli Lilly and Company (NYSE: LLY), a stalwart in the healthcare sector, has consistently demonstrated its prowess in the pharmaceutical industry. With a market capitalization nearing $954 billion, Eli Lilly..

Vertex Pharmaceuticals (VRTX) Stock Analysis: A Biotech Leader with 8% Potential Upside

Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX), a titan in the biotechnology sector, has long been a beacon for innovation, primarily focusing on the treatment of cystic fibrosis (CF). With a market..

Danaher Corporation (DHR) Stock Analysis: Exploring a Potential 11.93% Upside with Strong Buy Ratings

Danaher Corporation (NYSE: DHR), a titan within the healthcare sector, has consistently demonstrated its prowess in the diagnostics and research industry. With a robust market capitalization of $168.28 billion, Danaher..

AstraZeneca PLC (AZN) Stock Analysis: Promising Growth with a 6.56% Potential Upside

AstraZeneca PLC (AZN), a heavyweight in the healthcare sector, continues to capture investor attention with its robust pipeline and strategic collaborations. As a leading biopharmaceutical company headquartered in Cambridge, UK,..

UnitedHealth Group (UNH) Stock Analysis: Navigating Healthcare’s Robust Performer with a 10.53% Upside Potential

UnitedHealth Group Incorporated (NYSE: UNH) is a titan in the healthcare sector, commanding a market capitalization of $322.71 billion. As a diversified healthcare company, it operates through four main segments:..

Emergent BioSolutions Inc. (EBS) Stock Analysis: Is the 11.66% Upside Worth the Risk?

Emergent BioSolutions Inc. (NYSE: EBS), the Maryland-based life sciences company, is drawing attention from investors with its potential upside of 11.66%. Known for its extensive portfolio of preparedness and response..

Rapport Therapeutics, Inc. (RAPP): Investor Outlook with an 87% Potential Upside

Rapport Therapeutics, Inc. (NASDAQ: RAPP) is rapidly making waves in the biotechnology sector with its focus on developing breakthrough therapies for central nervous system (CNS) disorders. With a market capitalization..

AngioDynamics, Inc. (ANGO) Stock Analysis: Exploring an 81.88% Potential Upside

AngioDynamics, Inc. (NASDAQ: ANGO), a key player in the medical technology sector, has caught the eye of investors with its compelling growth potential. With a market capitalization of $438.14 million,..

Enhabit, Inc. (EHAB) Stock Analysis: Exploring a 5.39% Potential Upside in Healthcare

As Enhabit, Inc. (EHAB) continues to solidify its presence in the healthcare sector, investors are closely watching its performance within the medical care facilities industry. Based in Dallas, Texas, Enhabit..

InnovAge Holding Corp. (INNV) Stock Analysis: Navigating Healthcare with Revenue Growth and a Cautious Outlook

InnovAge Holding Corp. (NASDAQ: INNV), operating within the healthcare sector as a provider of medical care facilities, has been capturing attention with its distinct approach to senior care. Headquartered in..

PureTech Health plc (PRTC): Biotechnology Gem with a Staggering Revenue Growth of 542.70%

PureTech Health plc (PRTC) is emerging as a standout player in the biotechnology sector, captivating the attention of investors with its remarkable revenue growth and cutting-edge innovations. Based in Boston,..

Treace Medical Concepts, Inc. (TMCI) Stock Analysis: Exploring a Potential 81% Upside

Treace Medical Concepts, Inc. (NASDAQ: TMCI), a player in the healthcare sector’s medical devices industry, is making waves with its innovative solutions for bunion correction and midfoot deformities. Based in..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds